Kenneth Thermann Kongstad

Kenneth Thermann Kongstad is an Assistant Professor at the Department of Drug Design and Pharmacology within the Faculty of Health and Medicinal Sciences at the University of Copenhagen. His research spans interdisciplinary projects at the intersection of analytical chemistry, spectroscopy, biochemistry, and pharmacology. He has established an endophyte research lab focused on discovering novel drug leads from microorganisms living within plants, a largely unexplored area in natural product research with significant potential. His work bridges analytical science with pharmacological applications through collaborations with the Pharmacotherapy Research section and other departments.

Dr. Kongstad's educational background includes:

• PhD from the Faculty of Pharmaceutical Sciences at University of Copenhagen, supervised by Prof. Jerzy W. Jaroszewski (deceased) and Dr. Manfred Spraul
• MSc. Eng. from Technical University of Denmark (DTU), with research conducted at University of Queensland, Australia under Prof. Rob Capon

His primary research interests focus on the discovery of future drug leads from endophytic fungi, quantitative analysis of opioids for pharmacokinetic studies, and chemical characterization of bioengineered organisms. Dr. Kongstad specializes in advanced hyphenated NMR techniques ($$\text{HPLC-PDA-HRMS-SPE-NMR}$$) for natural product research and pharmaceutical applications. His work has developed innovative screening methodologies for semi-high-throughput analysis of plant extracts and identification of bioactive metabolites responsible for antifungal activity. He maintains active collaborations with research groups at Department of Plant and Environmental Sciences (KU), Department of Bioengineering and Biomedicine (DTU) and various departments within KU.

Analysis of Dr. Kongstad's recent publications reveals a strong focus on applying advanced analytical techniques to identify bioactive compounds with therapeutic potential. His work spans diabetes research (particularly $$\alpha$$-glucosidase inhibitors), cancer research (multidrug resistance reversal), and pain management (opioid pharmacokinetics). A common thread is the integration of sophisticated analytical methodologies with biological activity screening to accelerate drug discovery from natural sources, especially endophytic fungi and plant extracts.

Dr. Kongstad has received professional recognition including:

• Teacher of the Year (2019)

He has established significant research collaborations across multiple institutions and has been involved in multiple funded research projects, including the DSF-funded 'FungalFight' project and collaborative efforts to develop cell factories for producing carminic acid. His endophyte research lab serves as a hub for interdisciplinary research, bringing together expertise in natural product chemistry, pharmacology, and analytical science. He has also filed two patents related to cell factory development for carminic acid production.

His laboratory focuses on chemical and biological characterization of endophytic fungi, with particular attention to compounds with antifungal, antidiabetic, and other therapeutic properties. The lab integrates advanced analytical techniques with biological screening to identify bioactive metabolites. Dr. Kongstad's team collaborates extensively with researchers specializing in pharmacokinetic modeling, contributing to the development of personalized medicine approaches. He has also maintained editorial roles for journals including Natural Product Research, Analytical Methods, and Journal of Separation Science.